Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Completed

Conditions studied: Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer

In brief

The overall objective of this study is to assess turnaround time, pre-BRCA test onco-genetic counselling quality and satisfaction with a new onco-genetic BRCA testing model.

Key facts

Study ID
NCT02406235
Run by
AstraZeneca
People needed
710
Starts
2015-04-21
Expected to finish
2016-09-30
Last updated by the study team
2017-09-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.